# CLOBETASOL PROPIONATE
> **ANDA211240** · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2022-02-17
## Drug
- **FDA Application Number:** ANDA211240
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOBETASOL PROPIONATE
- **Generic name:** CLOBETASOL PROPIONATE
- **Active ingredients:** CLOBETASOL PROPIONATE
- **Dosage form:** SOLUTION
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** QUAGEN
- **Manufacturer:** Quagen Pharmaceuticals LLC
- **First approval:** 2022-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211240)
---
*AI Analytics · CC0 1.0*